C84.44
Peripheral T-cell lymphoma, not elsewhere classified, lymph nodes of axilla and upper limb
Clinical Classification Guidelines
Medical Intelligence & Overview
Peripheral T-cell lymphoma (PTCL) is a type of non-Hodgkin lymphoma that originates from mature T-cells, a kind of white blood cell vital for immune defense. The ICD-10 code C84.44 specifically refers to PTCL affecting lymph nodes located in the axilla (armpit area) and upper limb. This form of lymphoma is relatively rare and can be aggressive, requiring comprehensive evaluation and treatment. Understanding its characteristics, causes, symptoms, and approaches to diagnosis can help patients better grasp the nature of this condition.
Causes & Symptoms
Clinical Causes: Genetic mutations leading to abnormal T-cell growth Chronic immune stimulation or inflammation Infections such as certain viruses (though less common) Environmental exposures, although specific risk factors are not well established History of prior immune system disorders or treatments
Key Symptoms: Swollen lymph nodes in the armpit and upper arm area Unexplained weight loss Persistent fever and night sweats Fatigue and weakness Localized pain or tenderness over affected lymph nodes Sometimes, skin lesions or lumps
Diagnostic & Treatment
Diagnosis Path: Diagnosing peripheral T-cell lymphoma involves several steps to confirm the presence and specific characteristics of the disease. Typically, the process includes: - Physical examination focusing on lymph node regions - Imaging studies such as CT scans or PET scans to determine the extent of lymph node involvement - Biopsy of an affected lymph node to identify abnormal T-cells and determine the subtype of lymphoma - Laboratory tests, including blood counts and blood chemistry - Additional molecular or genetic testing may be used to guide treatment planning Accurate diagnosis is crucial in establishing the disease's stage and planning appropriate therapy.
Treatment Protocols: Treatment options for peripheral T-cell lymphoma affecting the axilla and upper limb usually involve a combination of therapies tailored to the individual patient. These may include: - Chemotherapy regimens designed to kill lymphoma cells - Targeted therapies that aim at specific molecules involved in the growth of lymphoma cells - Radiotherapy to control localized disease - Stem cell transplantation in cases of aggressive or relapsed disease - Supportive care to manage symptoms and improve quality of life Since PTCL can be challenging to treat, the management plan is typically coordinated by a multidisciplinary team of healthcare providers, including hematologists and oncologists.
Clinical Advice & FAQs
Billing Guidance
Is C84.44 a billable ICD-10 code?
Yes, C84.44 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C84.44?
Clinical documentation must specify the nature of Peripheral T-cell lymphoma, not elsewhere classified, lymph nodes of axilla and upper limb and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
